Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M961Revenue $M37.0Net Margin (%)-140.4Altman Z-Score-2.2
Enterprise Value $M787EPS $-0.3Operating Margin %-244.0Piotroski F-Score1
P/E(ttm)--Beneish M-Score10.6Pre-tax Margin (%)-140.4Higher ROA y-yN
Price/Book7.510-y EBITDA Growth Rate %-29.4Quick Ratio3.5Cash flow > EarningsN
Price/Sales21.05-y EBITDA Growth Rate %-45.7Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-61.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M242ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARNAKen Fisher 2013-12-31 Buy $4.08 - $6.66
($5.22)
$ 3.97-24%New holding11,000
ARNAMario Gabelli 2011-03-31 Sold Out $1.41 - $2.16
($1.7)
$ 3.97134%Sold Out0
ARNAMario Gabelli 2010-12-31 Buy $1.27 - $2.38
($1.58)
$ 3.97151%New holding13,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARNA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WOODS RANDALL EDirector 2015-03-30Sell76,268$4.49-11.58view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-20.6view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-36.58view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-27.69view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-32.14view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-32.14view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-43.69view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-43.29view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-37.08view
Nova Tina SusanDirector 2014-04-14Sell35,000$6.22-36.17view

Quarterly/Annual Reports about ARNA:

News about ARNA:

Articles On GuruFocus.com
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
(ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW Apr 07 2013 
comment on ARNA Mar 15 2013 
comment on ARNA Mar 02 2013 
WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC Oct 07 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 
Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
Vivus Could Rocket on Success of Qnexa Apr 13 2012 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 

More From Other Websites
Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference... Jul 30 2015
Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference... Jul 30 2015
Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for... Jul 29 2015
8:02 am Arena Pharm initiates a Phase 2 proof-of-concept clinical trial of APD334 in ulcerative... Jul 29 2015
Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for... Jul 29 2015
Westaim Provides Update On Status Of Arena Transactions Jul 21 2015
Anti-Obesity Drugs in the US – Technavio Evaluates Trends, Forecast, & Growth Prospects Jul 20 2015
3 Biotech Stocks to Trade Off the Receptos Buyout Jul 15 2015
Wednesday's Mid-Day Movers: Does The U.S. Benefit From Iran Deal?; Celgene-Receptos And More Jul 15 2015
Celgene Hits High As Street Applauds Receptos Buyout Jul 15 2015
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 09 2015
17/2015 - Conclusion of an agreement for the purchase of Expo Arena Jul 06 2015
Arena Pharmaceuticals (ARNA) Stock Declines on CFO Departure Jun 17 2015
Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's After-Hours Movers Jun 16 2015
After-hours buzz: DavidsTea, La-Z-Boy, Adobe & more Jun 16 2015
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Jun 16 2015
Arena Pharmaceuticals Announces the Departure of Chief Financial Officer Jun 16 2015
Arena Pharmaceuticals Announces the Departure of Chief Financial Officer Jun 16 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK